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Sleep deprivation is ubiquitous in hospital settings and deleterious to patients’ health. 
Specifically, sleep deprivation has been reported to play a role in multiorgan dysfunction, 
leads to poor critical illness outcomes, and can be considered a risk factor for delirium, a 
highly prevalent disease in intensive care units with even greater implications. To date, 
there are no evidence-based pharmacological interventions for sleep deprivation, and 
have even resulted in more adverse effects. However, non-pharmacological solutions 
have had limited efficacy, displaying a need for novel therapeutic options. In this 
randomized control trial, we will investigate and compare mean lengths of total 
sleep time between weighted blankets and standard of care in adults hospitalized in 
intensive care units. This non-pharmacological intervention for sleep deprivation may 
help enhance sleep and improve overall health outcomes. 
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CHAPTER 1: INTRODUCTION 
1.1 Background 
1.1.1 Sleep and Critical Care 
Sleep is a crucial physiological process and plays a central role in promoting overall 
health.1 Sleep deficiency is an encompassing term including short sleep duration, poor 
sleep quality, and abnormal sleep timing. Chronic sleep deficiency has been shown to 
have a negative effect on cardiovascular disease, cancer, diabetes, depression, and 
immune function.1,2 Similarly, acute sleep deficiency has been found to increase the risk 
of both infectious and inflammatory diseases, and contribute to all-cause mortality. 3-5 
Figure 1: Aspects of sleep deficiency 
 
Research shows that poor sleep is especially ubiquitous and deleterious in patients in 
critical care settings, at a time when their body arguably most needs adequate sleep for 
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healing, research.6  In the intensive care unit (ICU), patients have been found to 
experience a all domains of sleep deficiency (i.e. short sleep duration, poor quality sleep, 
and abnormal sleep timing). Polysomnography (PSG), the gold standard in the objective 
measurement of sleep, studies have demonstrated a decrease in total sleep time, frequent 
awakenings, and changes in sleep stages including dramatic decreases in slow wave and 
rapid eye movement (REM) sleep stages.7 Patients also have circadian rhythm disruptions 
with increased poor-quality daytime sleep and more frequent nighttime awakenings. In 
the hospital, environmental factors such as increased noise pollution, abnormal lighting 
schedule, and frequent around-the-clock care can lead to sleep deficiency.7-9 Other 
contributing factors to poor sleep include chronic sleep disorders, acute illness-related 
factors, and medical interventions such as medications. In addition, the stress and anxiety 
of requiring ICU admission can contribute to insomnia, as emotional state and difficulty 
initiating/maintaining sleep have proven to be interrelated.10 As an average length of stay 
in an ICU can span multiple nights, the culmination of all of these factors can lead to 
profound acute sleep deprivation. This has been found to have long-standing implications 
of sleep deficiency in critically ill patients up to twelve months after hospital discharge.11  
Sleep deprivation can play a role in multiorgan dysfunction that hinders critical 
illness recovery and thus leads to poor critical illness outcomes. One current area of 
investigation is the overlap between sleep deprivation and ICU delirium. Delirium is an 
acutely, reversible disturbed state of mind characterized by restlessness, illusions, and 
incoherence of thought and speech. Delirium is highly prevalent in the ICU and is 
associated with increases in mortality, cognitive impairment and hospital length of 
stay.12-14 There have also been studies demonstrating increase in days of delirium in the 
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ICU being directly related to increase in 1-year mortality.15 Sleep deprivation and 
delirium are believed to share similar mechanisms in neurohormonal changes and 
imbalances in neurotransmitters. Experimentally, specific regional brain activity shown 
on lesion studies and functional imaging studies implicate the prefrontal and the 
nondominant parietal cortices for both.14 Clinically, the two issues are similar in poor 
thought processing, attention and memory deficits, and fluctuating mental status. Studies 
have found that quality improvement interventions to improve sleep have been associated 
with significant improvement in incidence of delirium.16 Given the interrelatedness of the 
two conditions, sleep deprivation can be considered a possible modifiable risk factor for 
delirium, a condition which, as discussed, has tremendous implications in the critical care 
setting. 
Sleep deprivation is pervasive in the hospital, especially in the ICU. There are no 
evidence-based pharmacologic interventions available to treat sleep deprivation or 
delirium in the critically ill and efforts to enhance sleep medically can result in even more 
adverse effects. For this reason, non-pharmacological strategies may prove to be more 
efficacious.17 Some non-pharmacological interventions have been explored including 
earplugs and eye masks, aromatherapy massage, and cluster nursing care during night 
time hours.18-20 These interventions have shown some promise for subjective perceptions 
of sleep. The lack of concrete options and objective measures of outcome for non-
pharmacological interventions for sleep deficiency leaves more to be explored. 
1.1.2 Measuring Sleep 
 In general, measuring sleep in the ICU is difficult to carry out. The gold standard 
for diagnosing sleep disorders has been overnight, in-laboratory PSG. PSG includes 
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measures of EEG (electroencephalogram), electrooculogram (EOG), chin and limb 
electromyogram, oronasal flow, thoracoabdominal movement, electrocardiogram, and 
pulse oximetry. 21 PSG has been adapted to be more portable and can be left on patients 
in the ICU without direct observation. However, PSG has a high cost, practical 
difficulties with implementation, and can be uncomfortable for patients who are critically 
ill. 
 An alternative to PSG is actigraphy, a small accelerometer sensor that measures 
levels of physical activities and distinguishes between periods of wakefulness and sleep 
through body motions. It is worn on the wrist similar to a watch and has no tethering 
wires. In normal healthy adult populations, actigraphy has significant correlation and 
agreement with PSG.22 Its primary use in clinical practice is in the assessment of sleep 
schedules and sleep quality in a non–critically ill population; however, a few studies have 
used actigraphy to measure sedation/agitation in the ICU.23 These studies indicate that 
actigraphy correlates with nurse-directed observation of agitation, sleep, and sedation in 
alert and calm patients.24 For Total Sleep Time (TST), a frequently used measure of 
sleep, agreement between actigraphy and PSG has been shown to be above 90%.25 For 
these reasons, actigraphy better option for longitudinal monitoring and is a less invasive, 
less cumbersome, and more cost-effective method to objectively measure sleep. 
 For a subjective measure of sleep, the Richards Campbell Sleep Questionnaire 
(RCSQ) is the only validated tool in critically ill patients. The RCSQ has been found to 
significantly correlate with corresponding PSG measures.26 The items are constructed on 
a visual analog scale (VAS), which has study subjects mark a point on a line that 
indicates intensity of sensation. The benefit of this style of questioning is that it only 
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requires ill patients with declined physical stamina to make a single tick mark. RCSQ is 
able to add a subjective measure in a validated way against objective measures like PSG 
and actigraphy. 
1.1.3 Weighted Blankets 
Weighted blankets are blankets of various sizes filled with beads, chain, or other 
materials to increase the weight of a standard sleeping blanket in an even distribution. 
They have been increasingly used in various settings as a method of providing Deep 
Touch Pressure (DTP), or Deep Pressure Stimulation (DPS), to alleviate anxiety and 
increase sleep in various populations. DTP is a type of touch pressure that provides 
mechanical stimulation and deformation of the skin and underlying tissues, and has been 
compared to the sensation of a firm hug, holding, swaddling, or massage. It has been 
shown to improve arousal modulation, leading to a feeling of calmness.27 Outcomes such 
as symptom severity in neonates with neonatal abstinence syndrome (NAS) and 
autonomic responses while undergoing third molar extractions have been evaluated.27,28 
However, the primary focus of weighted blanket studies have been in sleep and anxiety. 
 Weighted blankets have been studied in the context of sleep in a wide variety of 
patient populations with a range of results. Two separate weighted blankets studies on 
sleep deficiency. A quasi-experimental study found that weighted blankets decreased 
insomnia and sleep disturbance in children with autism spectrum disorder (ASD).29 A 
level IV single-subject design study similarly found that weighted blankets decreased 
insomnia, but in adults with chronic insomnia.30 Another study, a randomized control 
trial (RCT) on children with ASD found that weighted blankets did not improve objective 
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sleep quality, but that they were favored by participants and subjectively contributed to 
better sleep.29  
 Weighted blankets use has also been studied in anxiety. A RCT with crossover 
design was performed in outpatient chemotherapy infusion center, and was shown to 
reduce anxiety among patients receiving chemotherapy when the blanket was used.31 
Another exploratory study discovered that 78% of non-hospitalized participants self-
reported being more relaxed when using weighted blankets.32 In a pilot study of weighted 
blankets in acute inpatient psychiatric units, individuals who used the weighted blanket 
reported significantly greater reductions in distress.33 As previously mentioned, ICU 
admission has been linked to increased anxiety, and anxiety has been linked to sleep 
disturbance in a mutually influencing cycle.30 A key mechanism of minimizing sleep 
disturbance in the ICU would be the mitigation of anxiety. 
1.2 Statement of the Problem 
Sleep deficiency is pervasive in the critically ill, with no evidence-based 
pharmacological interventions shown to be effective. Pharmacological interventions can 
lead to increased adverse effects and drug interactions. For this reason, non-
pharmacological strategies must continue to be explored.  Currently, the Yale New Haven 
Hospital (YNHH) medical ICU has a sleep protocol in place utilizing some non-
pharmacological techniques, in which from midnight to 4:00 AM, there are no overhead 
pages, no routine labs or diagnostic testing, and an effort to cluster care by the nursing 
staff. In addition, patients receive a quiet pack with a card to remind all to be courteous 
with noise levels, ear plugs, headphones, and an eye mask. There is no formal signal or 
cue to sleep. There are limited options other than those currently provided to all patients. 
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Despite these interventions, patients still report poor sleep in the hospital, with 
disturbances lasting even after discharge.11 For this reason, it is necessary to continue 
evaluating different approaches. 
Weighted blankets have been shown to help with sleep and anxiety in a variety of 
populations and settings, including autistic children and adolescents, adult psychiatric 
inpatient centers, during dental procedures, breast cancer patients in inpatient and 
outpatient settings, and more. However, there is a lack of literature in this population of 
hospitalized critically ill adults, where sleep is especially critical, yet jeopardized.  
1.3 Goals and Objectives 
The overall goal of this study is to investigate whether weighted blankets increase 
overnight sleep in adult critically ill patients. In this randomized control trial, the primary 
aim is to investigate and compare mean lengths of TST, measured by actigraphy, between 
weighted blankets and standard of care in adults hospitalized in the medical ICU. A 
secondary aim is to determine whether patients subjectively feel that the blanket 
improves their sleep via RCSQ and whether they enjoy the blanket’s use. 
1.4 Hypothesis 
Weighted blankets used in hospitalized patients over 50 years old in the medical ICU will 
be associated with an increase in mean TST (minutes) when compared to baseline of 
those with usual care. 
1.5 Definitions 
Weighted Blanket: A blanket of various sizes, filled with beads, chain, or other materials 
to increase the weight of a standard sleeping blanket in an even distribution. They have 
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been most often used within the scope of occupational therapy practice as a therapeutic 
modality. The theoretical framework of their use comes from the concept of Deep Touch 
Pressure (DPT). 
Deep Touch Pressure (DTP): Firm tactile sensory input that provides proprioceptive 
input to the whole body. Examples include firm hugs, firm stroking, cuddling, hugging, 
squeezing, compression, or swaddling that aims to relax the nervous system. It is 
considered a sensory-based intervention to relieve anxiety. 
Deep Pressure Stimulation (DPS):  DPS and DPT are often used interchangeably. For the 
purpose of this discussion, we will use DPT as the preferred term. 
Total Sleep Time (TST): The amount of time that a person spends actually asleep during a 
planned sleep episode.  
Actigraphy: The use of an actigraph to make a record of the activity level of the body, 
especially when measuring the amount and quality of sleep by sensing physical 
movement. An actigraph is a small device usually worn on the wrist. 
Richards Campbell Sleep Questionnaire (RCSQ): The only validated tool in critically ill 
patients to subjectively assess sleep. It is a composed of five questions that patients 
answer using a VAS (0-100mm). The questions relate to sleep depth, sleep latency, 







Table 1. Abbreviations used throughout proposal 
ICU  Intensive Care Unit 
PSG Polysomnography 
REM Rapid Eye Movement 
EEG Electroencephalogram 
EOG Electrooculogram  
TST Total Sleep Time 
RCSQ Richards Campbell Sleep Questionnaire  
VAS Visual Analog Scale 
DTP Deep Touch Pressure 
DPS Deep Pressure Stimulation 
NAS Neonatal Abstinence Syndrome 
ASD Autism Spectrum Disorder 
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CHAPTER 2: REVIEW OF THE LITERATURE 
2.1 Introduction 
 The literature review search was conducted with initial review in June 2020 and 
final review in March 2021 using PubMed, Ovid (Embase), and Cochrane. MeSH terms 
for primary searches included combinations of the terms “Intensive Care Units”, 
“Weighted Blankets”, “Sleep Disruption”, and “Sleep Disturbance”.  Additional search 
terms included “Deep Touch Pressure”, “Deep Pressure Stimulation”, “Chain Blanket”, 
“actigraphy”, “sleep-wake disorders”, and “critical illness.” Articles were filtered based 
on English language and analyzed for relevance to this proposed study. Additional 
pertinent articles were extracted and compiled from the references of relevant articles.  
Searches revealed over 1,500 articles related to sleep in the critically ill, which 
shows just how extensive, common, and deleterious sleep deprivation is in this 
population. Conversely, searches yielded less than 10 studies related to weighted 
blankets, demonstrating a gap in the literature, and the need for studies into this potential 
non-pharmacological approach to enhancing sleep. 
2.2 Review of Empirical Studies 
2.2.1 Sleep Deficiency in the ICU  
 ICUs have been a central location where physicians, nurses, and other healthcare 
staff have cared for the most critically ill since their inception in the 1960s.1 Given a 
multitude of factors, including chronic sleep disorders at baseline, acute critical illnesses, 
medical interventions, and the ICU environment, sleep in this setting is often deficient.2 
Sleep in the ICU meets all standards of sleep deficiency, such as short duration, 
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interrupted sleep, poor quality, and abnormal timing. Studies as early as 1971 identified 
sleep deprivation in the ICU, stating that “the situation becomes circular; the sicker the 
patient, the longer he must remain in the ICU.”3 While these studies occurred over five 
decades ago, the findings of poor sleep in hospitals, and especially in ICUs, hold true 
today. Studies continually attempt to evaluate sleep in ICUs objectively and subjectively. 
PSG is the gold standard method of measuring sleep in all settings and has been 
employed in studying the critically ill. In a study by Elliot, et. al., employing 24-hour 
PSG to evaluate 57 ICU patients, 90% of patients spent their TST in superficial sleep, 
meaning they are deprived by the most restorative sleep such as REM. In this population, 
TST was 5 hours, and 41% of the TST occurred during the day, showing the circadian 
rhythm disruption. This study stated that they were limited in patient enrollment due to 
the lack of PSG monitoring equipment available and lack of researchers trained in the 
interpretation of the PSG data. They concluded an alternative objective sleep assessment 
method would be more beneficial.4 Another study demonstrated that critically ill patients 
experienced 41±28 sleep periods within 24 hours, with sleep periods lasting 15±9 min, 
showing highly fragmented sleep.5 A feasibility study for accurate measure of sleep was 
carried out in an observational pilot study in a medical ICU. 24-hour PSG was conducted 
in 29 patients with indicators of feasibility including attainment of EEG data sufficient to 
determine sleep stages, sleep efficiency, and arousal indices. They found that EEG data 
was not affected by electrical interference. They concluded that unattended, portable PSG 
can produce high quality sleep data. However, in this study, a limitation was patient 
discomfort and transfers during recording time that truncated studies.6  
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While PSG remains the gold standard, it can be expensive, requires more 
extensive training for use and interpretation, and can be cumbersome and uncomfortable 
for patients. Actigraphy, an accelerometer worn on the wrist to track motion, has been 
validated against PSG in healthy populations as an objective measure of sleep.7 For TST, 
agreement between actigraphy and PSG has been shown to be above 90%.8 Actigraphy is 
less burdensome and expensive, and for these reasons, better for longitudinal studies. A 
cross-sectional study by Naik et. al in 2018 studied sleep in a tertiary hospital MICU with 
actigraphy. The TST (in minutes) was found to be 522±122 and did not differ 
significantly between good and poor perceived sleep. Limitations of this study included a 
sample size of convenience, lack of baseline or follow up actigraphy data in ward or post-
discharge for evaluation of contribution of ICU admission on sleep disturbance, lack of 
noise and light level documentations, and measuring sleep quality as a dichotomous 
variable, although it occurs in continuum. 9 
 Subjective sleep assessments have yielded similar results, in that sleep in critically 
ill patients was subjectively light, was often fragmented by frequent arousals, and that 
once awoken, it was difficult to resume sleep. RCSQ is the only validated subjective 
sleep assessment in the critically ill population compared to PSG, the gold standard.10 In 
one study, patients were screened for their sleep via RCSQ prior to admission to the 
surgical ICU and immediately one night after. When comparing the scores obtained in the 
ICU with their previous sleep scores, 55% of patients stated that their sleep had worsened 
in the ICU.11 A limitation in the applicability of this study is the all surgical patient 
population, but a strength is the fact that they found no difficulties in the use of RCSQ in 
this population. The same study by Elliot, et. al., previously discussed regarding PSG, 
 15 
showed that most of the patients evaluated their sleep as poor using the RSCQ, with the 
mean being 57.5 on the VAS, which correlated with PSG data of the same study.4 The 
same study by Naik et. al, previously discussed regarding actigraphy, showed that poor 
sleep (RCSQ <50, sensitivity 88% and specificity 87%) was found in 15 out of 37 
patients.9 General limitations of subjective measures are mental capacity changes in 
intensive care patients such as delirium that may alter responses and physical constraints 
that would limit the ability to complete a VAS.  
Through all of the different methods of measuring and evaluating sleep, it is clear 
that sleep deprivation is pervasive in the ICU. The causes of this poor sleep are numerous 
and can fall into different categories of effects on the brain (medications, head trauma, 
age), stress responses (crucial illness, inflammation). A major category with a large 
opportunity for investigations into interventions would be the ICU environment including 
light, noise, and sensory deprivation or overstimulation, and discomfort. 
2.2.2 Implications of Poor Sleep in the ICU 
The lack of sleep quality and quantity in all settings has great implications for 
patient outcomes. Acute sleep deficiency, including short sleep duration, has been found 
to have effects in the shorter term. Examples include cognitive changes, mood changes, 
metabolic effects such as short-term glucose intolerance, immune changes such as 
impaired adaptive immunity and increases in inflammation, and cardiac issues such as 
arrythmias.12-16 Chronic sleep deficiency has been linked to a number of longer-term 
effects. Chronic sleep loss has been found to lead to impaired vigilance and performance, 
slowing of cognitive processes, long term depression, and poor attention.17,18 Pulmonary 
function is affected by sleep deprivation through diminished respiratory response to 
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hypoxemia and hypercapnia.19 A meta-analysis looking at cross-sectional and 
longitudinal study data on sleep duration found that shorter sleep duration is associated 
with an increased risk of hypertension, with an odds ratio of 1.21 (95% CI, 1.09-1.34).20 
A prospective study found that difficulties initiating sleep were related to Coronary 
Artery Disease related death in males, with a relative risk of 3.1 (95% CI, 1.5-6.3, 
p<0.01).21 ICUs disturb sleep at a time when systems are often already most 
compromised or impaired. The list of complications of sleep deficiency is extensive and 
those that are critically ill are especially susceptible to these implications and their poor 
effects on patient outcomes.  
 A specific complication of sleep disturbance in the critically ill is the increased 
risk of delirium, while this association is still considered controversial. In one study, 52 
critically ill medical and surgical patients were studied with the intention of correlating 
sleep deprivation with the development of mental status changes, and found that mental 
status changes were more likely in patients with greater sleep deprivation22 A sleep QI 
project was conducted to understand the role of sleep promotion on ICU delirium in a 
medical ICU. They observed a significant reduction in the incidence of delirium/coma 
during the ICU stay and a significant increase in daily ICU delirium/coma-free status. 
However, secondary analysis of this data found that perceived sleep quality was unrelated 
to delirium transition (adjusted OR 1.00, 95% CI 0.99-1.00).23 While more studies need 
to be performed to determine the extent of the interrelatedness, many of the risk factors 
between the two overlap. Overlapping risk factors with direct effects on the brain include 
the medications used in critically ill such as sedation, dementia, sepsis, advanced age. 
Overlapping risk factors from the stress response include crucial illness, mechanical 
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ventilation, pain, inflammation. Lastly, overlapping ICU environment risk factors include 
noise, light and circadian disruption, and patient care activities.24 For this reason, 
interventions on sleep deficiency and deprivation may prove to help with delirium as 
well.  
The sleep deficiency and deprivation that the ICU can cause is not limited to the 
time spent in the hospital. In one study of 60 patients, 50% reported sleep disturbance 
during their time in the hospital, while 30% reported continued sleep disturbances up to 
one year post discharge.25 An observational cohort study of medical ICU patients showed 
that total medical ICU days of delirium (p=0.013) were significantly associated with 
higher levels of sleep disturbance at follow-up.26 The number of days of ICU delirium 
was found to be significantly associated with time to death within 1 year post-ICU 
admission, with a hazard ratio of 1.10 (95% CI, 1.02-1.18).27 An observational cohort 
study of 93 medical ICU patients with delirium aimed to evaluate associations between 
the loss of specific sleep features on EEG (K-complexes, sleep spindles), grade of 
encephalopathy, and ICU outcomes. They found that patients had more severe 
encephalopathy and higher odds of death when EEG showed a lack of K-complexes 
(odds ratio 18.8, p=0.046) and lack of sleep spindles (odds ratio 6.3, p=0.036).28 The 
short-term and long-term implications display the need for further research into 
interventions for sleep deprivation. 
2.2.3 Other non-pharmacological interventions for sleep 
 There are no pharmacological interventions proven to improve sleep in the ICU. 
In fact, some medications can cause more adverse effects, drug interactions, and patient 
harm than benefit. Daily sedative interruption is the only known pharmacological strategy 
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that improves PSG parameters in the ICU.29 Some ICU medications, such as 
benzodiazepines and opiates, may increase sleep time, but not restorative sleep. 
Melatonin has been considered for its sleep-promoting properties, but has mainly been 
studied using non-validated sleep measuring tools.30 Though promising, results to date 
have been mixed. Larger, RCTs with melatonin would need to be performed to fully 
understand its effect on sleep in this population.31,32 As such, non-pharmacological 
interventions are recommended as first line treatment and prevention by the graded 
guidelines for clinical practice in the prevention and management of Pain, 
Agitation/Sedation, Delirium, Immobility, and Sleep Disruption (PADIS).33  
The most common non-pharmacological sleep intervention is the premise of a 
quiet time protocol. A study in an ICU at a level 1 trauma center created a quiet time 
protocol, limiting noise and light during certain hours. Noise and light levels were 
recorded and patients were observed for sleep 30 minutes before and every half hour until 
30 minutes after the protocol. By simply enacting this protocol, there was a mean 
reduction in noise levels by 10 decibels (or two sound doublings) statistically significant 
at the 0.025 level. Light levels also decreased by 15-25% with p values less than 0.025. 
With these lower levels, patients were significantly more likely to be observed sleeping, 
with an odds ratio of 4.04 (97.5% CI, 2.24-7.30).34 A study was carried out to evaluate 
providers’ perceptions and practices regarding sleep in the ICU through surveys. A total 
of 1,223 surveys were completed from 24 countries, with most respondents indicating 
that ICU patients experienced “poor” or “very poor” sleep (75%) and that poor sleep 
could affect the ICU recovery process (88%). The minority (32%) of providers had sleep-
promoting protocols, despite most clinicians believing that sleep in the ICU is poor. 
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These findings highlighted discordant provider perceptions and practices around sleep in 
the ICU.35 A study at YNHH in the medical ICU tested the impact of a sleep promotion 
protocol on overnight in-room disturbance. The sleep protocol restricted non-urgent 
bedside care from 00:00 to 04:00. Patients were assigned to usual care or the sleep 
protocol. They found that the sleep time protocol arm had 32% fewer room entries (rate 
ratio 0.68, p=0.001) and 9 fewer minutes of in-room activity (p=0.0002). These findings 
proves that a sleep promotion protocol can provide better opportunities for sleep in the 
ICU.36  
 Interventions to block the ICU environment have been tried with some success. A 
RCT on patients in the cardiac surgical ICU studied effects of earplugs and eye masks, 
with subjective sleep quality evaluated using the Chinese version of the RCSQ. Data 
from 45 patients were analyzed, with significant differences in overall sleep quality 
(p<0.05). Patients perceived sleep quality was better in the group with the intervention. A 
limitation of this study was that it was solely a subjective measure, with no PSG or 
actigraphy data.37 Other studies have been able to show improvement in sleep via PSG in 
simulated ICU settings.37,38 An intervention review aimed to assess the efficacy of non-
pharmacological interventions for sleep promotion in critically ill adults in the ICU, but 
found that out of over 30 trials, the quality of evidence for an effect on any outcomes 
examined was generally low or very low. They used three of these trials with sufficient 
data for two separate meta-analyses. One meta-analysis showed a lower incidence of 
delirium during ICU stay (risk ratio 0.55, 95% CI 0.38-0.80, P value = 0.002) with use of 
earplugs or eye masks or both. The second meta-analysis showed a positive effect of 
earplugs or eye masks or both on TST (mean difference 2.19 hours, 95% CI 0.41-3.96, P 
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value = 0.02). However, this study rated the quality of the evidence for both of these 
results as low.39 Despite the potential benefits of eye masks and ear plugs, 80% of 
patients have been shown to decline these interventions, which inherently inhibits their 
ability to improve sleep deficiency.40 YNHH currently offers medical ICU patients a 
quiet pack including these items. 
Various relaxation techniques such as milk-honey drinks, massage, aromatherapy, 
and music have been evaluated through small studies and found to be effective. A unique 
intervention for sleep quality enhancement was considered in a clinical trial study in 
hospitalized patients with acute coronary syndrome. Patients in the intervention group 
received a warm, milk-honey mixture twice per day for three days, while the control 
group received routine care. Sleep quality was measured beforehand, and each day, using 
the RCSQ. There was no significant difference in sleep scores between the two groups on 
the first day of admission (p=0.914), but on the third day of admission, there was a 
significant difference in sleep scores between the intervention and control group 
(p=0.001). They concluded that the mixture of milk and honey improves subjective sleep 
of patients with ACS, and could be an affordable and simple intervention to offer.41 
Aromatherapy massage at bed time has been used in an experimental study in 
postoperative, hospitalized patients in the ICU. RCSQ indicated a statistically significant 
difference in sleep between the mean scores of the intervention group (aromatherapy 
massage, 54±13) and the control group (routine care, 29±9). They concluded that 
aromatherapy massage enhanced the sleep quality.42 A non-controlled clinical study was 
performed in ICUs in Italy to identify whether musical sounds in conjunction with a 
massage before bed affected sleep, evaluated using the RCSQ. Each patient chose their 
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favorite music or relaxing sounds of nature and they listened through headphones all 
night. After one night of the two interventions, significant improvements were observed 
in patient’s perception of the quality of sleep. For example, “depth of sleep” improved 
(t=2.01, p=0.04). A significant limitation of this study would be the design and lack of 
randomized control.43 
A meta-analysis of various sleep promoting interventions showed that in 13 
studies involving 296 critically ill patients, sleep quantity was improved (pooled 
standardized mean difference 0.37, 95% CI, 0.05 to 0.69, P=0.02) and quality through 
reduction in sleep fragmentation (pooled standardized mean difference -0.31, 95% CI, -
0.60 to -0.01, P=0.04).44 In summary, this shows that it is possible to continue to improve 
sleep through different interventions and options need to continue to be explored. 
2.2.4 Weighted blankets and Sleep 
Using the search terms previously discussed, we were able to find eight total 
journal articles on the topic of weighted blankets, which clearly displays the lack of 
literature on the topic. A systematic review by Eron done on weighted blankets and their 
role in both sleep and anxiety was performed in 2020, in which they evaluated eight 
studies. They were able to conclude that research suggests weighted blankets may be an 
appropriate therapeutic tool, especially in anxiety, but more research on sleep would need 
to be performed.45 
 One population where weighted blankets and their impact on sleep have been 
studied is in children with autism. This study was a RCT with the study objective of 
gauging the effectiveness of a weighted blanket intervention in treating severe sleep 
problems in this population. This was measured with actigraphy to analyze TST, powered 
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to 80% with 5% significance. This study used a paired t-test to compare the weighted 
blanket and control blanket, where the mean difference was -4.2 (34.5, 95% confidence 
interval (CI) -13.6 to 5.2). They concluded that there was no significant difference in TST 
between blankets. However, this study was able to display the safety of the use of these 
blankets, and parents were more likely to rate their child’s sleep as better, despite the 
objective evidence. The strengths of this study were that it was the first randomized study 
specifically designed and powered to assess the impact on TST in children with ASD, it 
included a “placebo” control, and used objective measures. The limitations included the 
lack of ability to mask weighted vs control blankets and that the study required a sample 
size of 63 patients, but only 54 subjects’ data was analyzed.46 
 A repeated measures study looked at the positive effects of weighted blankets on 
insomnia in adult populations, using sleep bout time, sleep latency, total wake time, and 
sleep fragmentation as measured through actigraphy. They concluded that the mean sleep 
bout time (in minutes), equivalent to TST, significantly increased (p=0.035) when using 
the weighted blanket, with a positive outcome on sleep both objectively and subjectively. 
A limitation of this study and source of potential bias that was not outwardly 
acknowledged was that their funding came from a weighted blanket company.47 
 A randomized controlled study of weighted chain blankets on insomnia, and 
sleep-related daytime symptoms for patients with major depressive disorder, bipolar 
disorder, generalized anxiety disorder, and attention deficit hyperactivity disorder. The 
outcome was evaluated using the Insomnia Severity Index (ISI), with sleep and daytime 
activity levels also measured by wrist actigraphy. At four weeks, they found that there 
was a significant advantage in ISI ratings of the weighted blanket intervention (p<0.001). 
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They concluded that weighted chain blankets are an effective and safe intervention for 
insomnia in this population.48 The only limitation suggested by this study was the risk of 
disclosure of the blanket-type to the rater, who was supposed to be blind to the treatment 
allocation, which they report only happened once throughout the study. 
 Lastly, a study on 2 children with ASD studied weighted blankets with an 
outcome measure of a daily online survey. Results showed that both participants achieved 
a slight increase (1-3 hour) in total sleep per night and a slight decrease in time to fall 
asleep per night. A clear limitation of this study is the sample size and power of the 
study.49 
 The systematic review by Eron summarized that the limitations in all of these 
studies on sleep and weighted blankets include a narrow sampling methodology, small 
sample sizes, the inability to blind experimental and control groups due to obvious weight 
differences in blankets, or low-level designs. 
2.2.5 Weighted Blankets with other related outcomes  
 In addition to studies on sleep, weighted blankets are being evaluated in the use of 
anxiety treatment in various settings and populations. Anxiety, as previously discussed, is 
highly prevalent in the critically ill, and is often tied to sleep quantity and quality. A RCT 
evaluated the effectiveness of weighted blankets on anxiety in adult patients receiving 
their first and second chemo infusions. The outcome was measured with a VAS over two 
days. Based on the scores, weighted blankets resulted in a larger reduction in anxiety 
after 30 minutes compared to no blanket. Weighted blanket use was associated with a 
reduction in the VAS scores by a mean of 8.89 points (95% CI, 15.69, 1.18) at 30 
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minutes. A major limitation of this study was that a “convenience sample was used, with 
the reasoning that a small sample size would be used to first determine effect and 
feasibility of future studies.50 To assess the safety and effectiveness of the use of a 30-
pound weighted blanket in adult inpatient acute psychiatric settings, an exploratory pilot 
study was employed using safety metrics of pulse, blood pressure, and pulse oximetry. 
They found that there was a statistically significant improvement identified in self-rating 
anxiety data (p=0.002).51 
 A pilot study of a sensory room in an acute inpatient psychiatry unit aimed to 
measure distress in patients and staff perceived disturbed behaviors (loud, pacing, 
irritable, paranoid, etc.) before and after use of the room. The rooms included weighted 
blankets, music, rocking chairs, and aromatherapy. The study showed that those 
individuals who used the weighted blanket specifically, significantly reduced distress and 
clinician-rated anxiety than those who did not.52 
 Weighted blankets have also been used as interventions for various different 
outcomes of measure related to sympathetic nervous system responses. A randomized 
controlled crossover design was used in adolescents who were undergoing third molar 
extraction. The results indicated that third molar extraction caused significant autonomic 
parameter changes in both groups, with weighted blanket and without. However, the deep 
pressure input in the experimental group was associated with less heart rate variability, 
which they suggest reveals a more balanced sympathovagal activation.53 A crossover 
RCT was conducted at a level III neonatal ICU to assess the safety, feasibility, and 
effectiveness of weighted blankets in the care of neonates with NAS. A total of 16 
patients were enrolled for a total of 67 weighted blanket sessions, and there was found to 
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be a significant decrease in the infant’s heartrate (decrease of 7 beats per minute, 
p=0.011, effect size r=0.448). In addition to this, Finnegan scores, a scoring method of 
severity of symptoms in babies with NAS, decreased when a weighted blanket was 
used.54 The study, notably, only found these effects to be while the blanket was in use, 
and did not persist when re-checked 30 minutes after taking the blanket off. 
 In summary, weighted blankets have been used in various other settings and with 
other outcomes of measure, but similarly regarded as a tool for calming patients, which 
can reasonably lead to decreased anxiety, or in our study, enhanced sleep through 
increase in TST. 
2.3 Review of Relevant Methodology 
The following section will be a review of the literature in the context of relevant 
methodology to the study being proposed, while more detailed methods, explanations, 
and justifications can be found in Chapter 3. 
2.3.1 Study Design 
 The proposed study will be a RCT with two arms: weighted blankets and usual 
care. It will take place in the medical ICU at YNHH in New Haven, CT. 
 RCTs are the gold standard for determining the effectiveness of an intervention as 
it allows to control for “unknown variables.” The decision to do an RCT will also be 
beneficial given the previous lack of RCTs in the study of non-pharmacological 
interventions for sleep and in weighted blanket use. As discussed previously, non-
pharmacological intervention studies have not frequently utilized RCTs. An RCT was 
carried out to test the impact of sleep promotion protocols on in-room disturbances.36 One 
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RCT measured sleep subjectively with the RCSQ in cardiac surgical ICUs with an 
intervention of earplugs and an eye mask.37 Other studies utilized RCTs to study milk and 
honey mixtures or aromatherapy.41,42 These studies were limited by being solely 
subjective measures and contained smaller sample sizes.  
 There have been four major RCTs for the study of weighted blankets, but only 
two of which were studies pertaining to sleep. One weighted blanket that focused on 
sleep was an RCT on insomnia in psychiatric disorders in an adult outpatient population. 
This study found that at 4 weeks, insomnia decreased using a severity index. However, 
they found that there was no significant effect on TST. Participants subjectively reported 
an improvement in ability to maintain sleep, despite lack of increase in TST. A strength 
of this study was the controlled design and large sample size.48 Another RCT that 
investigated weighted blankets and sleep focused on children with autism and found that 
TST had no significant difference between intervention and control. However again, 
subjectively, the participants preferred the blankets.46 The two other RCTs studied 
anxiety in patients undergoing chemotherapy and Finnegan scores for babies with NAS, 
and both studies showed promising results of decreased anxiety and symptom 
severity.50,54 The lack of RCTs with objective data, on non-pharmacological interventions 
with large enough sample sizes, and on weighted blankets and sleep especially in 
inpatient settings demonstrates a need for such a study. 
 The study site will be YNHH’s medical ICU, which admits over 4,000 patients 
per year. This study site is appropriate as it allows this study to recruit enough 
participants to have a significant sample size. The number of patients and the 
heterogenicity of the study population given the urban metropolitan area will allow for 
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generalizability of results. Most commonly, with the patient population we aim to use 
discussed further in chapter 3.2, the reason for admission will include septic shock and GI 
bleed. While this does not provide for a wide variety of diagnoses, most hospitals across 
the US have medical ICUs with similar patient population make-ups, allowing for 
generalizability. This study will also have a primary outcome of objective data and a 
secondary outcome of subjective data. A strength of this design would be adding 
objective data, but also collecting subjective data to be able to compare to previous 
studies, which largely use this measure. 
2.3.2 Selection Criteria 
Previous studies in YNHH’s medical ICU through Dr. Knauert’s Lab have 
included patients that were admitted from home less than 24 hours prior to enrollment. 
Patients were excluded if they were expected by medical staff to leave the ICU, or 
expected to die in the next 24 hours (i.e., receiving comfort care only).36 The proposed 
study will similarly incorporate these criteria. 
Graded guidelines for clinical practice in the prevention and management of Pain, 
Agitation/Sedation, Delirium, Immobility, and Sleep Disruption (PADIS) in adult 
patients in the ICU were published by thirty-two international experts who met monthly 
to assess data in each category. This panel assessed risk factors before ICU admission for 
sleep deficiency, and found that older age and specific premorbid conditions (i.e., 
hypertension, diabetes, cancer, and thyroid disease) have been consistently reported as 
being associated with perceived lower quality of sleep in the ICU.33 Another study 
concluded that patients with poor sleep had a higher median age (43 vs 31 years, 
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P=0.008).11 Given this information, the proposed study will focus on patients of older 
age.  
Weighted blankets have been determined to be safe at 10% of body weight by two 
studies.51,55 However, these blankets have not been studied in the critically ill population. 
Based on weighted blanket guidelines and blankets commercially available, previous 
studies have also excluded patients who weigh less than 45kg.50 For this reason, using 
best clinical judgement, we will exclude those with any wounds (open, surgical, pressure, 
etc.), those in respiratory failure, and those weighing less than 45kg upon admission. 
2.3.3 Potential Confounding Variables 
 Confounding variables threaten the validity of a study’s findings. One source of 
potential confounding would be frequently used medications in the ICU, including 
sedatives. Medications, including sedating medications, can cause changes in the amount 
and quality of sleep. These medications can affect the Central Nervous System directly, 
through the blood brain barrier, or indirectly, by interfering with a medical or psychiatric 
condition. They can have equally disturbing effect when withdrawn abruptly.56 
Benzodiazepine, a sedative, may improve sleep efficiency because of decreased sleep 
latency, decreased number of arousals, and increased TST. However, the chronic use of 
benzodiazepines is associated with superficial sleep and withdrawal is associated with 
rebound insomnia. Propofol, which is used primarily for deep sedation, such as when 
someone is on mechanical ventilation, suppresses REM sleep and can be associated with 
delirium.57,58 Medications are necessary in ICUs and are unavoidable. For the proposed 
study, we will limit the confounding variable of known medications that interfere with 
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sleep by excluding those in respiratory distress, who are often on ventilators and therefore 
under sedation. 
Another potential confounding variable would be reported sleep quality or use of 
regular sleep aid medication at home. In three studies, these factors have been 
consistently reported as being associated with perceived lower quality of sleep in the 
ICU.40,59,60 We will record home medication list as baseline variables during enrollment 
and will control for this variable. 
2.3.4 Randomization and Blinding 
 Randomization of participants will be via simple randomization with assignment 
via random number generator to either intervention or control with a 1:1 allocation. This 
is based on previous studies carried out by the Knauert Lab in YNHH’s medical ICU. In 
one pilot study, they studied implementation of a sleep promotion protocol in the medical 
ICU on overnight in-room disturbance, where the primary measures were sound and 
light. Randomization was carried out using a computerized random number generator and 
a 1:1 allocation to the intervention and control groups and allowed for a reduced 
possibility of bias from confounding variables in enrolled patients.36 Previous weighted 
blanket studies have similarly used this 1:1 allocation, using a concealed lottery 
method.48 
 The blinding of the proposed study will blind participants to the hypothesis and 
the content of other treatment groups through specific consent phrasing, discussed in 
Chapter 3.6. Other weighted blankets have struggled to find methods of blinding 
participants given the weighted nature of the blanket.46,50,52,53 Two studies have created 
control blankets that matched in size and fabric, but are not weighted.48 For the purpose 
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of our study, we will consent patients to a more broad idea of “non-pharmacological 
sleep interventions” and not specifically mention the blanket as our intervention of 
interest. The control group will still be provided with standard non-pharmacological 
interventions of eye mask and earplugs. Our proposed study, for this reason, should have 
more protection against information bias. In accordance with weighted blanket studies, 
investigators and research assistants interpreting outcome will be blinded to subject 
allocation at baseline and during assessment points.46,53 
2.3.5 Intervention 
 The intervention will be a weighted blanket. There are countless brands of 
weighted blankets, made of different materials and different weights, some being 
considered medical grade, while others not. Some studies have used metal chain-
weighted blankets or blankets filled with heavy beads that can be purchased and some 
studies have manufactured their own blankets. 47,50,53 
 No previous research was found that supported a validated weight or pressure 
recommendation for weighted blanket therapy. However, manufacturers of different 
weighted blankets, such as Mosaic Weighted Blankets, Price, and Sensory Direct, publish 
guidelines for their products. Most consistently, manufacturers recommend a weighted 
blanket should be 10% of an individual’s body weight. Some research studies have been 
performed and have found this weight to be safe, and even recommend weights more 
than 10%.51,55  
An ideal weighted blanket for our study would contain small, stitched “bladders”, 
or contained sections, of beads. These small sections would allow the weight to stay fixed 
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and not shift with blanket manipulation, which is important for consistent and effective 
DTP. For the purpose of our study, we also wanted to use a blanket that would be able to 
be sanitized and reused between patients. We will use blankets that are closest to 10% of 
an individual’s body weight, as this is the recommended weight from manufacturers, it 
has been found to be safe, and we do not want blankets to be too heavy or be considered 
restraint.  
 A study by Vinson on patients undergoing chemotherapy used a blanket most in 
line with our ideal blanket, obtained from CapeAble Weighted Products. This blanket is 
34 inches by 62 inches with an outer antimicrobial fabric. The inner bladders were 
stitched in small sections and filled with clean recycled glass beads. In this study, they 
were easily wiped clean after each patient’s use with Sani-Cloth germicidal disposable 
wipes, which are currently stocked on YNHH’s medical ICU.50 
2.3.6 Primary and Secondary Outcome Measures 
 The primary outcome for the proposed study will be TST (in minutes), which has 
been used in countless sleep studies and is a common basic measure of sleep.4,5,9 TST has 
also been used in numerous weighted blanket studies and sleep.46-48 The primary outcome 
will be measured by actigraphy. As previously discussed, actigraphy has been validated 
against the gold standard, PSG in healthy populations.7 For TST, the agreement between 
actigraphy and PSG has been shown to be above 90%.8 The actigraph will be used on the 
non-dominant wrist, as it has been in other weighted blanket studies.46,48 
 However, it is worth acknowledging the drawbacks in using TST or actigraphy 
based on the literature. In the sole two RCTs on weighted blankets and sleep, the 
outcome of TST was not significantly affected by the weighted blanket use.46,48 Despite 
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this, given that there are only two total studies with limited sample size with this 
intervention, and no RCTs with this intervention, outcome, and critically ill population, 
we still feel TST will be a useful primary outcome for this proposed study. In addition, 
actigraphy’s validity in critically ill populations is still unclear.  An observational study 
with simultaneous PSG, actigraphy, and behavioral assessments from nursing concluded 
that actigraphy overestimated TST and that the agreement between the two was <65%. 
Their explanation was the few changes in body position made it difficult for the 
actigraphy to measure sleep. However, this was a single study with a sample size of 12.61 
A systematic review in 2018 concluded that actigraphy is being used more frequently as a 
surrogate measure of sleep, but is limited by processing algorithms. They determined that 
prior ICU-based studies using actigraphy were heterogenous and lacked data. Larger, 
more rigorous, and standardized studies are needed to better understand its role.62 As we 
are specifically excluding patients in respiratory failure, who are often intubated, sedated, 
and restrained, which would severely limit wrist motion and measurements via 
actigraphy, we hope to overcome some of the limitations.  
 In addition, a study by Sadeh in 2011 suggested that given these limitations of 
actigraphy, it is best that a complementary assessment measure should be used whenever 
possible.63 For this reason, our proposed study’s secondary outcome will be the RCSQ 
global scale, or total five subsections of the RCSQ, and each subsection individually. As 
previously discussed in Chapter 2.2.1, RCSQ has been validated against PSG in medical 
ICU patients evaluating aspects of nighttime sleep including 1) depth, 2) latency (time to 
fall asleep), 3) number of awakenings, 4) efficiency (percent time awake), and 5) 
quality.10 The proposed study will be novel as RCSQ, a valid and commonly used sleep 
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assessment, has not yet been used to evaluate weighted blankets as an intervention, 
especially concurrently with objective measures. 
2.3.7 Sample Size and Statistical Significance 
TST has been found to have significant variation across studies in the critically ill. 
For example, one study by Elliot et.al. in critically ill patients found TST to be 
approximately 5 hours, or 300 minutes. In another study by Naik et. al., TST in minutes 
the crucially ill was found to be 522±122 minutes. When using weighted blankets as an 
intervention, a study by Gringas found TST to be 452±59 minutes. For this reason, we 
determined that we will use preciously collected data from Dr. Knauert’s Lab for which 
the manuscript is in process. Advantages of using this data includes using the same 
sample population, same environmental conditions as it will be the same medical ICU 
where the study will take place, and the same actigraph devices and program for data 
interpretation will be used. The historical data from YNHH’s medical ICU showed an 
overnight TST of 94 minutes, with a high degree of variance of 61 minutes.  
There have been no studies on weighted blankets in this critically ill population. 
Weighted blanket studies have used powers of 80% and alpha of 0.05.46,47 There have 
also been no direct studies on effect size. One weighted blanket study used data from a 
pilot study on 5 participants to calculate an effect size. Using Cohen’s d, an effect size of 
0.75 was determined to be appropriate.47 Other non-pharmacological interventions, as 
discussed in Chapter 2.2.3, have largely used RCSQ as their primary outcome, rather than 
TST, and therefore do not provide any insight on effect size.34,37,41-43,64-66 Most studies 
with TST have been aiming to validate actigraphy against other measures, such as PSG, 
and therefore did not include an effect size. For this reason, it is difficult to determine an 
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appropriate effect size. Using best clinical judgement, we decided that 20% increase in 
sleep (18 minutes when using data from Dr. Knauert’s historical data) would be an 
appropriate effect size. 
Given this data and designs of previous studies, for a power of 80% and alpha of 
0.05, and an effect size of 20% increase in sleep (18 minutes), the calculated sample size 
is 324 participants, or 162 per group. For more information, please refer to Chapter 3.9.  
2.4 Literature Review Conclusion 
Upon reviewing the literature, it became clear that sleep deficiency is pervasive in 
the critical care setting and has implications on patient outcomes in the short and long 
term. Pharmacological interventions may cause side effects, or otherwise decrease sleep 
quality. Non-pharmacological interventions have been explored, but with limited studies 
that are mostly subjective in nature, and with inconclusive results. Weighted blankets 
have subjectively shown promise in both sleep and anxiety. Sleep disturbance can often 
be linked to anxiety or emotional distress of being hospitalized. Weighted blankets have 
not been studied extensively in an objective way, such as actigraphy. The few studies that 
have made an attempt lacked generalizability, had small sample sizes, and were not in the 
critically ill population. They have also lacked simultaneous objective and subjective 
measures, which our proposed study will offer. We propose an RCT comparing usual 




1. Kelly FE, Fong K, Hirsch N, Nolan JP. Intensive care medicine is 60 years old: 
the history and future of the intensive care unit. Clin Med (Lond). 2014;14(4):376-
379. 
2. Knauert MP, Haspel JA, Pisani MA. Sleep Loss and Circadian Rhythm 
Disruption in the Intensive Care Unit. Clin Chest Med. 2015;36(3):419-429. 
3. Dlin BM, Rosen H, Dickstein K, Lyons JW, Fischer HK. The problems of sleep 
and rest in the intensive care unit. Psychosomatics. 1971;12(3):155-163. 
4. Elliott R, McKinley S, Cistulli P, Fien M. Characterisation of sleep in intensive 
care using 24-hour polysomnography: an observational study. Crit Care. 
2013;17(2):R46. 
5. Freedman NS, Gazendam J, Levan L, Pack AI, Schwab RJ. Abnormal sleep/wake 
cycles and the effect of environmental noise on sleep disruption in the intensive 
care unit. Am J Respir Crit Care Med. 2001;163(2):451-457. 
6. Knauert MP, Yaggi HK, Redeker NS, Murphy TE, Araujo KL, Pisani MA. 
Feasibility study of unattended polysomnography in medical intensive care unit 
patients. Heart Lung. 2014;43(5):445-452. 
7. Raj R, Ussavarungsi K, Nugent K. Accelerometer-based devices can be used to 
monitor sedation/agitation in the intensive care unit. Journal of Critical 
Care.29(5):748-752. 
8. Ancoli-Israel S, Cole R, Alessi C, Chambers M, Moorcroft W, Pollak CP. The 
role of actigraphy in the study of sleep and circadian rhythms. Sleep. 
2003;26(3):342-392. 
9. Naik RD, Gupta K, Soneja M, Elavarasi A, Sreenivas V, Sinha S. Sleep Quality 
and Quantity in Intensive Care Unit Patients: A Cross-sectional Study. Indian J 
Crit Care Med. 2018;22(6):408-414. 
10. Richards K. Techniques for measurement of sleep in critical care. Focus Crit 
Care. 1987;14(4):34-40. 
11. Nicolás A, Aizpitarte E, Iruarrizaga A, Vázquez M, Margall A, Asiain C. 
Perception of night-time sleep by surgical patients in an intensive care unit. Nurs 
Crit Care. 2008;13(1):25-33. 
12. Irwin MR. Why sleep is important for health: a psychoneuroimmunology 
perspective. Annu Rev Psychol. 2015;66:143-172. 
13. Brouwer A, Asare Bediako I, Paszkiewicz RL, Kolka CM, Bergman RN, 
Broussard JL. Impact of sleep deprivation and high-fat feeding on insulin 
sensitivity and beta cell function in dogs. Diabetologia. 2020;63(4):875-884. 
14. Jha PK, Foppen E, Kalsbeek A, Challet E. Sleep restriction acutely impairs 
glucose tolerance in rats. Physiol Rep. 2016;4(12). 
15. Jitomir J, Willoughby DS. Cassia cinnamon for the attenuation of glucose 
intolerance and insulin resistance resulting from sleep loss. J Med Food. 
2009;12(3):467-472. 
16. Ozer O, Ozbala B, Sari I, et al. Acute sleep deprivation is associated with 
increased QT dispersion in healthy young adults. Pacing Clin Electrophysiol. 
2008;31(8):979-984. 
 36 
17. Cohen DA, Wang W, Wyatt JK, et al. Uncovering Residual Effects of Chronic 
Sleep Loss on Human Performance. Science Translational Medicine. 
2010;2(14):14ra13. 
18. Banks S, Dinges DF. Behavioral and Physiological Consequences of Sleep 
Restriction. J Clin Sleep Med. 2007;03(05):519-528. 
19. White DP, Douglas NJ, Pickett CK, Zwillich CW, Weil JV. Sleep deprivation and 
the control of ventilation. Am Rev Respir Dis. 1983;128(6):984-986. 
20. Guo X, Zheng L, Wang J, et al. Epidemiological evidence for the link between 
sleep duration and high blood pressure: A systematic review and meta-analysis. 
Sleep Medicine. 2013;14(4):324-332. 
21. Mallon L, Broman JE, Hetta J. Sleep complaints predict coronary artery disease 
mortality in males: a 12-year follow-up study of a middle-aged Swedish 
population. Journal of Internal Medicine.251(3):207-216. 
22. Helton MC, Gordon SH, Nunnery SL. The correlation between sleep deprivation 
and the intensive care unit syndrome. Heart Lung. 1980;9(3):464-468. 
23. Kamdar BB, Niessen T, Colantuoni E, et al. Delirium transitions in the medical 
ICU: exploring the role of sleep quality and other factors. Crit Care Med. 
2015;43(1):135-141. 
24. Weinhouse GL, Schwab RJ, Watson PL, et al. Bench-to-bedside review: delirium 
in ICU patients - importance of sleep deprivation. Crit Care. 2009;13(6):234. 
25. Franck L, Tourtier JP, Libert N, Grasser L, Auroy Y. How did you sleep in the 
ICU? Crit Care. 2011;15(2):408. 
26. Altman MT, Knauert MP, Murphy TE, Ahasic AM, Chauhan Z, Pisani MA. 
Association of intensive care unit delirium with sleep disturbance and functional 
disability after critical illness: an observational cohort study. Ann Intensive Care. 
2018;8(1):63. 
27. Pisani MA, Kong SYJ, Kasl SV, Murphy TE, Araujo KLB, Van Ness PH. Days 
of delirium are associated with 1-year mortality in an older intensive care unit 
population. Am J Respir Crit Care Med. 2009;180(11):1092-1097. 
28. Knauert MP, Gilmore EJ, Murphy TE, et al. Association between death and loss 
of stage N2 sleep features among critically Ill patients with delirium. J Crit Care. 
2018;48:124-129. 
29. Oto J, Yamamoto K, Koike S, Imanaka H, Nishimura M. Effect of daily sedative 
interruption on sleep stages of mechanically ventilated patients receiving 
midazolam by infusion. Anaesth Intensive Care. 2011;39(3):392-400. 
30. Bourne RS, Mills GH, Minelli C. Melatonin therapy to improve nocturnal sleep in 
critically ill patients: encouraging results from a small randomised controlled trial. 
Crit Care. 2008;12(2):R52. 
31. Mo Y, Scheer CE, Abdallah GT. Emerging Role of Melatonin and Melatonin 
Receptor Agonists in Sleep and Delirium in Intensive Care Unit Patients. J 
Intensive Care Med. 2016;31(7):451-455. 
32. Marra A, McGrane TJ, Henson CP, Pandharipande PP. Melatonin in Critical 
Care. Crit Care Clin. 2019;35(2):329-340. 
33. Devlin JW, Skrobik Y, Gélinas C, et al. Clinical Practice Guidelines for the 
Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, 
 37 
and Sleep Disruption in Adult Patients in the ICU. Crit Care Med. 
2018;46(9):e825-e873. 
34. Dennis CM, Lee R, Woodard EK, Szalaj JJ, Walker CA. Benefits of quiet time 
for neuro-intensive care patients. Journal of Neuroscience Nursing.42(4):217-224. 
35. Kamdar BB, Knauert MP, Jones SF, Parsons EC, Parthasarathy S, Pisani MA. 
Perceptions and Practices Regarding Sleep in the Intensive Care Unit. A Survey 
of 1,223 Critical Care Providers. Ann Am Thorac Soc. 2016;13(8):1370-1377. 
36. Knauert MP, Pisani M, Redeker N, et al. Pilot study: an intensive care unit sleep 
promotion protocol. BMJ Open Respir Res. 2019;6(1):e000411. 
37. Hu RF, Jiang XY, Hegadoren KM, Zhang YH. Effects of earplugs and eye masks 
combined with relaxing music on sleep, melatonin and cortisol levels in ICU 
patients: a randomized controlled trial. Crit Care. 2015;19(1):115. 
38. Wallace CJ, Robins J, Alvord LS, Walker JM. The effect of earplugs on sleep 
measures during exposure to simulated intensive care unit noise. Am J Crit Care. 
1999;8(4):210-219. 
39. Hu RF, Jiang XY, Chen J, et al. Non-pharmacological interventions for sleep 
promotion in the intensive care unit. Cochrane Database Syst Rev. 
2015;2015(10):Cd008808. 
40. Kamdar BB, King LM, Collop NA, et al. The effect of a quality improvement 
intervention on perceived sleep quality and cognition in a medical ICU. Crit Care 
Med. 2013;41(3):800-809. 
41. Fakhr-Movahedi A, Mirmohammadkhani M, Ramezani H. Effect of milk-honey 
mixture on the sleep quality of coronary patients: A clinical trial study. Clin Nutr 
ESPEN. 2018;28:132-135. 
42. Özlü ZK, Bilican P. Effects of Aromatherapy Massage on the Sleep Quality and 
Physiological Parameters of Patients in a Surgical Intensive Care Unit Afr J Tradit 
Complement Altern Med. 2017;14(3):83-88. 
43. Pagnucci N, Tolotti A, Cadorin L, Valcarenghi D, Forfori F. Promoting nighttime 
sleep in the intensive care unit: Alternative strategies in nursing. Intensive Crit 
Care Nurs. 2019;51:73-81. 
44. Poongkunran C, John SG, Kannan AS, Shetty S, Bime C, Parthasarathy S. A 
meta-analysis of sleep-promoting interventions during critical illness. Am J Med. 
2015;128(10):1126-1137.e1121. 
45. Eron K, Kohnert L, Watters A, Logan C, Weisner-Rose M, Mehler PS. Weighted 
Blanket Use: A Systematic Review. Am J Occup Ther. 
2020;74(2):7402205010p7402205011-7402205010p7402205014. 
46. Gringras P, Green D, Wright B, et al. Weighted blankets and sleep in autistic 
children--a randomized controlled trial. Pediatrics. 2014;134(2):298-306. 
47. Ackerley. Positive effects of a weighted blanket on insomnia. Journal of Sleep 
Medicine & Disorders. 2017. 
48. Ekholm B, Spulber S, Adler M. A randomized controlled study of weighted chain 
blankets for insomnia in psychiatric disorders. J Clin Sleep Med. 2020. 
49. Gee BM, Peterson TG, Buck A, Lloyd K. Improving sleep quality using weighted 
blankets among young children with an autism spectrum disorder. International 
Journal of Therapy and Rehabilitation. 2016;23(4):173-181. 
 38 
50. Vinson J, Powers J, Mosesso K. Weighted Blankets: Anxiety Reduction in Adult 
Patients Receiving Chemotherapy. Clin J Oncol Nurs. 2020;24(4):360-368. 
51. Champagne T, Mullen B, Dickson D, Krishnamurty S. Evaluating the Safety and 
Effectiveness of the Weighted Blanket With Adults During an Inpatient Mental 
Health Hospitalization. Occupational Therapy in Mental Health. 2015;31(3):211-
233. 
52. Novak T, Scanlan J, McCaul D, MacDonald N, Clarke T. Pilot study of a sensory 
room in an acute inpatient psychiatric unit. Australas Psychiatry. 2012;20(5):401-
406. 
53. Chen HY, Yang H, Chi HJ, Chen HM. Parasympathetic effect of deep pressure 
input on third molar extraction in adolescents. J Formos Med Assoc. 
2019;118(9):1317-1324. 
54. Summe V, Baker RB, Eichel MM. Safety, Feasibility, and Effectiveness of 
Weighted Blankets in the Care of Infants With Neonatal Abstinence Syndrome: A 
Crossover Randomized Controlled Trial. Adv Neonatal Care. 2020. 
55. Mullen B, Champagne T, Krishnamurty S, Dickson D, Gao RX. Exploring the 
Safety and Therapeutic Effects of Deep Pressure Stimulation Using a Weighted 
Blanket. Occupational Therapy in Mental Health. 2008;24(1):65-89. 
56. Weinhouse GL. Pharmacology I: effects on sleep of commonly used ICU 
medications. Crit Care Clin. 2008;24(3):477-491, vi. 
57. Pulak LM, Jensen L. Sleep in the Intensive Care Unit: A Review. J Intensive Care 
Med. 2016;31(1):14-23. 
58. Kamdar BB, Needham DM, Collop NA. Sleep deprivation in critical illness: its 
role in physical and psychological recovery. J Intensive Care Med. 
2012;27(2):97-111. 
59. Bihari S, Doug McEvoy R, Matheson E, Kim S, Woodman RJ, Bersten AD. 
Factors affecting sleep quality of patients in intensive care unit. J Clin Sleep Med. 
2012;8(3):301-307. 
60. McKinley S, Fien M, Elliott R, Elliott D. Sleep and psychological health during 
early recovery from critical illness: an observational study. J Psychosom Res. 
2013;75(6):539-545. 
61. Beecroft JM, Ward M, Younes M, Crombach S, Smith O, Hanly PJ. Sleep 
monitoring in the intensive care unit: comparison of nurse assessment, actigraphy 
and polysomnography. Intensive Care Med. 2008;34(11):2076-2083. 
62. Schwab KE, Ronish B, Needham DM, To AQ, Martin JL, Kamdar BB. 
Actigraphy to Evaluate Sleep in the Intensive Care Unit. A Systematic Review. 
Ann Am Thorac Soc. 2018;15(9):1075-1082. 
63. Sadeh A. The role and validity of actigraphy in sleep medicine: an update. Sleep 
Medicine Reviews. 2011;15(4):259-267. 
64. Locihová H, Axmann K, Padyšáková H, Fejfar J. Effect of the use of earplugs and 
eye mask on the quality of sleep in intensive care patients: a systematic review. J 
Sleep Res. 2018;27(3):e12607. 
65. Walder B, Francioli D, Meyer JJ, Lancon M, Romand JA. Effects of guidelines 
implementation in a surgical intensive care unit to control nighttime light and 
noise levels. Critical Care Medicine.28(7):2242-2247. 
 39 
66. Engwall M, Fridh I, Johansson L, Bergbom I, Lindahl B. Lighting, sleep and 
circadian rhythm: An intervention study in the intensive care unit. Intensive Crit 
Care Nurs. 2015;31(6):325-335. 
  
 40 
CHAPTER 3: METHODS 
 
3.1 Study Methodology  
This study design will be a blinded RCT of usual care (control) versus weighted blankets 
(intervention). 
3.2 Study Population and Study Site 
 This study will take place at Yale-New Haven Hospital, a 1,500 bed, tertiary, 
academic hospital. We will recruit from the Medical Intensive Care Unit (MICU), which 
contains 38 beds and admits over 4,000 patients per year. The median MICU stay at Yale 
is three nights. All patients will be evaluated for eligibility daily as they are admitted to 
the ICU. The population will be critically ill adults. 
Enrollment must occur within 24 hours of hospital admission (as of 08:00 on the 
day of enrollment). Adults 50 years and older and patients that weigh over 45kg admitted 
to the medical ICU are eligible for inclusion. Participants must also be able to read and 
write in English in order to fill out a written survey. The exclusion criteria include 
respiratory failure and active wounds (open, surgical, pressure, etc.). Patients that are 
expected by their care team to leave within the next 24 hours will also be excluded. 
Therapy will be started on the first night following enrollment.  
3.3 Recruitment 
We will evaluate all admitted ICU patients daily. If the patient is unable to 
consent for themselves, consent will be obtained from the patient’s legally authorized 
representative. Patients or legal representatives that agree to the study will be informed 
that the study is investigating “different non-pharmacological sleep interventions”. 
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Research staff will inform the patient or legal representative of risks and benefits. 
Recruitment and enrollment will be on a rolling basis over eighteen months. 
3.4 Subject Protection and Confidentiality 
 YNHH’s medical ICU will be IRB approved under the Yale Human Investigation 
Committee (HIC). All members of the research team will participate in Health Insurance 
Portability and Accessibility Act (HIPAA) training prior to the start of the study. All 
information regarding the patient will be obtained through the hospital approved 
electronic health record, Epic, or directly from the patient. Each participant or 
representative will be informed of risks and benefits of the study and be informed of the 
confidentiality they will be provided with opportunities to ask questions. They will be 
provided with the IRB-approved Authorization and Consent form (see Appendix A) and 
will be asked sign the form indicating understanding and consent. 
Confidentiality will be maintained throughout the study. Once a participant enters 
the study, they will be assigned a unique identifier number. Videotaping will occur for 
one night during the study, on study night two, and the camera will be positioned at the 
top of the bed such that only the body and blanket will be visible. The participant’s face 
and other identifying features will not be visible. Following the scoring of the video for 
hours of blanket use, the video will be destroyed. 
Once extracted, data will be stored in REDCap, a program on a Yale University 
secure server with standard encryption. Any hard copies of data such as notes or surveys 
taken while abstracting will be shredded per hospital and/or university mechanism 
(approved shredding bins). Data management procedures will ensure accurate and 
efficient data storage and analysis; confidentiality; and real-time, on-demand study 
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monitoring reports. All data will be maintained in accordance with HIPAA guidelines for 
participant confidentiality and privacy. All data will reside on secure, HIPAA-compliant 
data base and file-sharing resources managed by Yale ITS. Access to data resources will 
strictly be limited to members of the research team. Data or information will never be 
placed on any portable devices such as flash drives and will only be placed on local 
networks, not accessible outside of the secure Yale environment. 
3.5 Assignment of the Intervention 
 After obtaining informed consent, patients will be randomized using a simple 
randomization tool through a program, REDCap. Baseline characteristics will be 
recorded and assigned to the participant’s unique study identification number. The 
intervention group will be weighted blanket with standard of care and the control group 
will be standard of care alone. Investigators will not have access to participant data 
before allocation. 
3.6 Study Variables and Measures 
Overall study timeline: patient will be enrolled and then randomized per above. Then on 
the first night of the study, they will be exposed to usual care or intervention for an 
acclimation night. Adherence will be monitored and outcome measures including 
actigraphy and subjective sleep scores will be collected based on study night two. 
Weighted Blanket Intervention: The intervention will be a weighted blanket that will be 
worn for a minimum of one hour per night’s sleep. The brand of the medical-grade 
weighted blankets will be CapeAble Products for consistency with other studies. Another 
benefit of using this blanket is its ability to be sanitized between uses, as discussed in 
Chapter 2. There will be three weights- 13.2lb, 17.6lb, or 22lb, (6, 8, or 10kg)- and 
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patients will wear use the blanket that is closest to 10% of their body weight (rounding 
up). Participants will be encouraged, when possible, to wear the blanket while sleeping, 
and they will be instructed that the study is based on the amount of time the blanket is in 
use. These patients will also be provided with the standard of care, discussed below. 
Patients will have the option to use the blanket for the rest of their hospital stay. The 
blankets will be returned to be sanitized and used again. We will operationalize the 
outcome variable with means of TST, measured with actigraphy. The weighted blanket 
intervention will be initiated within 24 hours of patient admission. 
Standard of Care: The control will be standard of care, where patients will be provided 
with a quiet pack that the hospital currently provides all patients. Patients will not be 
informed that this is standard of care, but rather that this is their “intervention”. This 
includes an eye mask, ear plugs, and headphones to listen to the television to minimize 
noise for other patients. Other quiet time protocols will continue to be followed. 
Overnight pages are eliminated from 0000 to 0400. Nursing is expected to cluster their 
care to the best of their ability. Patients have blankets, heated blankets, and sheets 
available for their comfort. 
Fidelity:  Patient will consent to being videotaped on night 2 of use of blanket. 
Participants’ faces will not be included in the video as the camera will only point toward 
the lower half of the body and area that the blanket will cover. A research assistant will 
view these videos once to assess for adherence, recorded based on the study’s unique 
patient identifier number, and these videos will be later destroyed for confidentiality and 
privacy purposes. Adherence will be considered one hour of continuous blanket use. 
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Primary and Secondary Outcomes:  Both the primary and secondary outcome will be 
based on data collection from night two of the study. The primary outcome will be TST 
in minutes measured via actigraphy on night two of the study. TST will be considered a 
continuous variable. The actiwatch data will be uploaded to Phillips Actiware 6 (or 
current version) and TST will be determined via the program’s standard algorithms. The 
secondary outcome will be a qualitative study on the patients’ subjective sleep quality on 
night two of the study. This will be measured with the RCSQ, the only validated 
subjective sleep questionnaire for ICU patients (see Appendix B). The questionnaire will 
be administered on morning three of the study, immediately after night two. Lastly, 
patients will be asked if they subjectively enjoy using the blanket in an exit interview on 
day seven (see Appendix C). 
Baseline Variables: The age, gender, presence of regular use of sleep aid medication, 
admission diagnosis, and nursing staff for night two of the patients’ stay (night of 
intervention and data collection) will be recorded as baseline variables. 
Monitoring of Adverse Events: Weighted blankets have been proven safe in various 
populations. However, we will be prepared in advance to manage adverse events. Patients 
will be informed that they may remove their intervention at any time desired or required. 
Nursing will be informed to continue to document any skin or respiratory changes and 
notify PI if conditions show any signs of worsening per unit protocol. PI will evaluate 
safety as needed and as necessary. 
3.7 Blinding of the Intervention and Outcome 
Blinding of the intervention: The patients will be informed that they will be a part of a 
non-pharmacological interventional sleep study. This is accurate as the intervention 
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(blanket) and standard of care (eye mask, earplugs) contain non-pharmacological sleep 
interventions. By phrasing the IRB study description and the interventions to the patients 
in this way, the participants can be blinded to the other interventions. Participants will 
also be blinded to the hypothesis. A daytime research assistant will consent the patient, 
set up the camera, and put the actigraph on participants’ wrists. Study participants will be 
randomly assigned to either the weighted blanket group or the standard of care group 
using the program REDCap. A second, night research assistant will implement the 
intervention or control. The following day, the daytime research assistant will return and 
administer the RCSQ. In this way, the research assistants can remain blinded to the 
intervention. 
Blinding of the outcome: The research assistant in charge of interpreting the actigraphy 
data and running statistics will be blinded to allocation. The research assistants 
interpreting the subjective RCSQ will remain blinded to the allocation.  
3.8 Data Collection 
Actigraphy wrist device will be placed on all participants at the same time on their 
non-dominant wrist. For the primary outcome, data collection and analysis will be based 
off of night two of use of the blanket/standard of care, as it will assume that all patients 
are accustomed to weight of blanket and the wearing of actigraphy. Patients will only be 
videotaped on this night to monitor for adherence. “Night” will be considered 8pm to 6 
am, as this is just after and before the noise/commotion of nursing shift change. We 
acknowledge that this is a broad window, but it will allow us to capture a wide range of 
nighttime sleep habits. Because our objective primary outcome is TST, it will not be 
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affected by a large window of sleep. Actigraphy data will be aggregated in Phillips 
Actiware 6 (or current version) and the program algorithms will determine TST.  
The secondary outcome of subjective sleep measures will be measured with the 
RCSQ. A research assistant who was blinded to the intervention will administer the 
RCSQ before noon on the day immediately following night 2 of the study. The RCSQ is 
a VAS questionnaire rated from 0-100 with five subsections (discussed in Chapter 1.6). 
Data will be collected for each section. 
Lastly, an exit interview will be performed for each patient in the intervention group. 
A research assistant will make contact with the patient, in person or via telephone, on day 
seven to gain a more qualitative understanding of the experience during the study. Please 
see Appendix C for exit interview script. 
3.9 Sample Size Calculation 
The statistical assumption to estimate sample size is based off of historical data in 
Yale’s MICU, collected by a study by Dr. Knauert for which the manuscript is in process. 
The overnight TST from this data set was found to be 94 minutes, with a high degree of 
variance of 61 minutes. Given this data, for a power of 80% and alpha of 0.05, and an 
effect size of 20% increase in sleep (18 minutes), the calculated sample size is 324 
participants, or 162 per group. To calculate, the ClinCalc online tool was used (see 




The primary outcome data will be analyzed using intention to treat. Secondary 
analysis will be performed with per protocol. The intervention and control groups will 
have TST averaged within groups. Given that TST, the primary outcome, is a continuous 
variable of means, a t-test will be used to study and compare the groups. The secondary 
outcome data will also be analyzed with intention to treat and secondary analysis of per 
protocol. The secondary outcome will be the RCSQ global scale (i.e. combined five 
subsections of the RCSQ). The global scale averages between intervention and control 
will be compared using a t-test.  Secondary analysis of the secondary outcome will be 
comparing the individual subsections of the RCSQ. Lastly, qualitative analysis will be 
performed to identify, consolidate, and review themes from the exit interview. 
3.11 Timeline and Resources 
The proposed study will occur over the span of two years. Past experience in the 
Knauert Lab suggests that at least 40 patients meeting age criteria per week are admitted 
to the MICU. However, respiratory failure is often the leading diagnosis and is expected 
to be present in approximately one-half of admitted patients over 50 years of age, thus 
reducing our estimate of eligible patients per week to 20. In addition, the Knauert Lab’s 
historic eligible to enroll rate is >25%. Therefore, we estimate conservatively the 
enrollment of 5 patients per week. To achieve our goal of enrollment of 330 study 
participants, we would need 66 weeks, or approximately 16 months, of active enrollment. 
We expect interruptions in enrollment for holidays, staff vacations, and day-light savings 
time (no enrollment during the week following start and stop), up to 8 weeks per year. 
Based on these numbers, we estimate that we will require approximately 18 months. 
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The timeline of the study will occur in three phases. Phase 1 will include IRB 
approval, database development, research staff training, and nursing in-service training, 
which will each occur over the course of three months. Phase 2 will include recruitment, 
enrollment, and data collection, which will each occur on a rolling basis over 18 months. 
Phase 3 will be analysis and manuscript composition, which will overlap the end of 
enrollment and occur in the nine months prior to study completion.  
Table 2: Tucked In Timeline 
"X" represents three months Year 1 Year 2 
Phase 1                 
     IRB approval X               
     Database Development X               
     Research Staff Training X               
     Nursing In-Service X               
Phase 2                 
     Recruitment   X X X X X X    
     Enrollment   X X X X X X    
     Data Collection   X X X X X X    
Phase 3                 
     Analysis           X  X X 
     Manuscript            X X X 
 
 The principal investigator (PI) for the study will be Dr. Melissa Knauert, MD, 
PhD. The co-principal investigator (co-PI) will be Jaime Conway, PA-SII. Two 
additional research assistants will be hired on an hourly basis for recruitment, enrollment, 
and data collection. The MICU at Yale is a total of 38 beds. There should be no more 
than ten currently enrolled patients at a time due to expected losses of eligibility and 
consent. The MICU Research Working Group has a library of equipment already 
purchased, which includes ten Actiwatch Spectrum Plus units and the associated 
 49 
programs for data interpretation. Video recording devices will also be obtained through 
the Working Group’s equipment library. 
The weighted blanket will be purchased from CapeAble Weighted Products in 
three weights (13.2lb, 17.6lb, or 22lb,) and will be produced such that it will be able to be 
wiped down and sanitized between patients with Sani-Cloth wipes (described further in 
Chapter 2.3.5). Four blankets in each weight category will be purchased for a total of 
twelve blankets. The approximate cost of these blankets will be $500 per blanket 
($6,000). 
3.12 Summary






















CHAPTER 4: CONCLUSION 
4.1 Advantages and Disadvantages  
 This study will be the first to use a blinded RCT design to compare the use of a 
weighted blanket to standard care with a goal of improving sleep in the adult critically ill 
population. Other non-pharmacological studies such as quiet time protocols, clustered 
care, earplugs, and eye masks have been studied with some success and are now 
implemented at YNHH.1-6 Other weighted blanket studies have attempted to improve 
sleep in different populations, but lacked significant sample sizes, combinations of 
objective and subjective data, or showed signs of bias.7-10 Through a randomized 
controlled design, we hope to gain insight into the benefits of a weighted blanket. We 
hope to limit bias through attempts at blinding and yield results with generalizability 
through a larger sample size than previous studies. Lastly, by measuring outcomes 
subjectively and objectively, we hope to allow for more compelling evidence for the 
benefits of weighted blanket use. 
 There are limitations to the proposed study that should be acknowledged. 
Blinding will be difficult given the weighted nature of the intervention and could cause 
bias on both the side of the research staff and of the participants. We will attempt to blind 
staff by 1) having separate research assistants apply intervention/control and collect 
subjective data and 2) collecting objective actigraphy data. We will attempt to blind 
participants through phrasing of the consent form as a “non-pharmacological 
interventions for sleep study.” Another limitation of our study would be the lack of 
heterogenicity of patient population. In the medical ICU, with our inclusion and 
exclusion criteria, we will be limited to a very specific subset of critical illnesses. 
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However, this should not limit generalizability, as most hospitals across the country 
would have medical ICUs with similar conditions. Lastly, the accuracy of actigraphy, an 
accelerometer based on body movement, can be limited in this population given the 
restricted movement of patients. We combat this issue through our exclusion criteria. By 
excluding those in respiratory distress, we are excluding those on mechanical ventilation 
who are sedated or restrained, thus precluding those that are moving less. In addition, by 
combining objective and subjective outcomes, we are able to compare and account for 
less movement. In summary, while there are limitations of the proposed study, measures 
were taken in development of the methods to mitigate these issues. 
4.2 Clinical Significance 
 Sleep deprivation in the ICU can adversely affect patient outcomes in the short 
and long term. Pharmacological interventions are not recommended as first line options 
as they have not been shown to help and can often have adverse effects.11-14 Non-
pharmacological options such as quiet time protocols, eye masks, and earplugs have 
proven successful. However, patients continue to have poor sleep in this setting. Given 
the limited number of options available for those suffering from sleep deprivation in the 
ICU, providers often find themselves distressed by the lack of potential solutions they can 
offer. In some cases, medical teams may even cause secondary harm with medications 
that are not approved, but used out of desperation to find an answer to the lack of sleep.  
For these reasons, depending on the results of the study, another non-
pharmacological option of a weighted blanket could be offered to patients as a solution to 
poor sleep. Weighted blankets, after initial investment, can be a cost-effective 
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intervention. In the clinical setting, the blanket may also prove to be a method of 
supporting patient satisfaction.  
While this study is limited to a specific population that is most vulnerable to sleep 
deficiency, it would have the potential to be applicable and extrapolated to a wider 
population with further study. Lastly, with limited research on weighted blankets, it 
would allow PAs and all providers in practice to better inform and guide patients when 
asked about or confronted with anecdotal evidence around weighted blankets relating to a 
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APPENDIX A: Authorization and Consent Form 
 
COMPOUND AUTHORIZATION AND CONSENT FOR PARTICIPATION IN A 
RESEARCH PROJECT 
YALE UNIVERSITY SCHOOL OF MEDICINE  
YALE NEW HAVEN HOSPITAL  
 
Study Title: TUCKED IN: WEIGHTED BLANKETS TO IMPROVE SLEEP IN 
INTENSIVE CARE UNIT PATIENTS 
Principal Investigator: Dr. Melissa Knauert, MD, PhD 
Co-Investigator: Jaime Conway, PA-SII 
Funding Source: Yale University School of Medicine Physician Associate Program  
 
Invitation to Participate and Description of Project 
 
You are invited to participate in a research study investigating different non-
pharmacological sleep interventions that aim to help sleep in intensive care units. You 
have been asked to participate because you have been admitted to the Medical Intensive 
Care Unit (MICU). Approximately 330 people will participate in this study.  
 
In order to decide whether or not you wish to be a part of this research study you should 
know enough about its risks and benefits to make an informed decision. This consent 
form gives you detailed information about the research study, which a member of the 
research team will discuss with you. This discussion should go over all aspects of the 
research: its purpose, the procedures that will be performed, any risks of the procedures, 
possible benefits, and possible alternative treatments. Once you understand the study, you 
will be asked if you wish to participate; if so, you will be asked to sign this form.  
 
Description of Procedures  
 
If you agree to participate in this study, you will be randomly assigned to one of two 
groups. Each group has a different non-pharmacological sleep intervention, meaning 
something that is not a medication that aims to enhance your sleep during your stay in the 
MICU. Examples include blankets, masks, earplugs. Random assignment is similar to 
flipping a coin; there is a 50% chance you end up in one group or the other. You will be 
asked to use your intervention while you sleep in the MICU.  
 
You will be asked to wear an actigraph, similar to a FitBit, which measures your sleep 
while you wear it, for two total nights. Your lower body will be video recorded, but your 
face and other identifying features will be obscured. You will be asked a series of 
questions the morning following your use of the intervention. As a courtesy, you will be 
able to use your intervention for the remainder of your stay in the hospital, should you 
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desire. You will be asked to participate in a 5-minute exit interview via telephone one 
week after the study completes. 
 
You will be told of any significant new findings that are developed during the course of 
your participation in this study that may affect your willingness to continue to participate. 
Research results will not be returned to your doctor. If research results are published, 
your name and other personal information will not be given.  
 
Risks and Inconveniences 
 
We do not anticipate any major risks in participating in this study. Potential risks would 
include discomfort while using your intervention, skin irritation from contact with 
different fabrics, or skin breakdown, though these are highly unlikely. 
 
There is a risk of breach of confidentiality about your health status and participation in 
this study, though this is unlikely to occur. All research staff will be thoroughly trained 




Benefits of participation in this study may include improvements in sleep, anxiety, and 
comfort while staying in the MICU. This study may also provide insight on improving 
your sleep outside of the hospital.  
 
Economic Consideration  
 
Your non-pharmacological intervention will be provided free of charge during your stay 
in the hospital. A promotional code will be provided to purchase your intervention from 
the manufacturer once you are discharged from the hospital. 
 
Treatment Alternatives/ Alternatives  
 
The alternative to participating in this study is to decline participation. If you do not wish 
to participate you will be provided the standard treatment. 
 
Confidentiality and Privacy  
 
Any identifiable information that is obtained in connection with this study will remain 
confidential and will be disclosed only with your permission or as permitted by U.S. or 
state law. Examples of information that we are legally required to disclose include abuse 
of a child or elderly person, or certain reportable diseases. Information will be kept 
confidential by using only identification numbers on study forms, storing signed forms in 
locked cabinets, and password protecting data stored on a computer. When the results of 
the research are published or discussed in conferences, no information will be included 




We understand that information about your health is personal, and we are committed to 
protecting the privacy of the information. If you decide to be in this study, the researcher 
will get information that identifies your personal health information. This may include 
information that might directly identify you, such as your name, birth date, or address. 
This information will be de-identified at the earliest reasonable time after we receive it, 
meaning we will replace your identifying information with a code that does not directly 
identify you. The principal investigator will keep a link that identifies you and your 
coded information, and this link will be kept secure and available only to the principal 
investigator or selected members of the research team. Any information that can identify 
you will remain confidential. The link to your personal information will be kept for 5 
years, after which time the link will be destroyed and the data will become anonymous. 
The data will be kept in this anonymous form indefinitely.  
 
The information about your health that will be collected in this study includes:  
 
• Research study records 
• Records about your time in the hospital 
• Records about phone calls made as part of this research  
 
Information about you and your health which might identify you may be used by or given 
to: 
 
Representatives from Yale University, the Yale Human Research Protection Program, 
and the Yale Human Investigation Committee (the committee that reviews, approves, and 
monitors research on human subjects), who are responsible for ensuring research 
compliance. These individuals are required to keep all information confidential.  
 
By signing this form, you authorize the use and /or disclosure of the information 
described above for this research study. The purpose of the uses and disclosures you are 
authorizing is to ensure that the information relating to this research is available to all 
parties who may need it for research purposes.  
 
All health care providers subject to HIPAA (Health Insurance Portability and 
Accountability Act) are required to protect the privacy of your information. The research 
staff at the Yale School of Medicine and those hospitals involved in this study are 
required to comply with HIPAA and to ensure the confidentiality of your information. 
You have the right to review and copy your health information in your medical record in 
accordance with institutional medical records policies. This authorization to use and 
disclose your health information collected during your participation in this study will 
never expire.  
 
Voluntary Participation and Withdrawal  
 
Participation in this study is voluntary. You are free to choose not to take part in this 
study. Refusing to participate will involve no penalty or loss of benefits to which you are 
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otherwise entitled (such as your health care outside the study, the payment for your health 
care, and your health care benefits). However, you will not be able to enroll in this 
research study and will not receive study procedures as a study participant if you do not 
allow use of your information as part of this study.  
 
Withdrawing from the Study 
 
If you do become a subject of this study, you are free to stop and withdraw at any time 
during its course.  
 
To withdraw from the study, you can inform nursing staff at any time and tell them you 
no longer wish to participate. You can simply remove your intervention and no longer 
use it. Withdrawing from the study will involve no penalty or loss of benefits to which 
you are otherwise entitled. You may withdraw or take away your permission to use and 
disclose your health information at any time. If you withdraw your permission, you will 
not be able to stay in this study. When you withdraw your permission, no new health 
information identifying you will be gathered after that date. Information that has already 
been gathered may still be used and given to others until the end of the research study, as 
necessary, to ensure the integrity of the study and/or study oversight.  
 




We have used some technical terms in this form. Please feel free to ask about anything 
you do not understand and to consider this research and the consent form carefully—as 




Authorization and Permission:  
I have read (or someone has read to me) this form and have decided to participate in the 
project described above. Its general purpose, the particulars of my involvement, and 
possible hazards and inconveniences have been explained to my satisfaction. My 
signature also indicates that I have received a copy of this consent form.  
By signing this form, I give permission to the researchers to use [and give out] 
information about me for the purpose described in this form. By refusing to give 
permission, I understand that I will not be able to be in this research study.  
 




_______________________________________            ________________ 
Signature of Person Obtaining Consent                           Date  
 
If after you have signed this form you have any questions about your privacy rights, 
please contact the Yale Privacy Officer at (203) 432-5919. 
 
If you have further questions about this project or if you have a research-related problem, 
you may contact the co-Principal Investigator, Jaime Conway. If you would like to talk 
with someone other than the researchers to discuss problems, concerns, and questions you 
may have concerning this research, or to discuss your rights as a research subject, you 
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APPENDIX D: Exit Interview 
 
INTERVENTION EXIT INTERVIEW 
 
1) During the past month, how would you rate your sleep quality overall? 
a. Very good 
b. Fairly good 
c. Fairly bad 
d. Very bad 
 
2) Did you use the blanket while sleeping? Y/N 
Comments: 
 
3) Did the blanket help you sleep better? Y/N 
Comments: 
 





APPENDIX E: Sample Size Calculation  
 
 




Ackerley. Positive effects of a weighted blanket on insomnia. Journal of Sleep Medicine 
& Disorders. 2017. 
Altman MT, Knauert MP, Murphy TE, Ahasic AM, Chauhan Z, Pisani MA. Association 
of intensive care unit delirium with sleep disturbance and functional disability after 
critical illness: an observational cohort study. Ann Intensive Care. 2018;8(1):63. 
Altman MT, Knauert MP, Pisani MA. Sleep Disturbance after Hospitalization and 
Critical Illness: A Systematic Review. Ann Am Thorac Soc. 2017;14(9):1457-1468. 
Ancoli-Israel S, Cole R, Alessi C, Chambers M, Moorcroft W, Pollak CP. The role of 
actigraphy in the study of sleep and circadian rhythms. Sleep. 2003;26(3):342-392. 
Baglioni C, Spiegelhalder K, Lombardo C, Riemann D. Sleep and emotions: a focus on 
insomnia. Sleep Med Rev. 2010;14(4):227-238. 
Banks S, Dinges DF. Behavioral and Physiological Consequences of Sleep Restriction. J 
Clin Sleep Med. 2007;03(05):519-528. 
Beecroft JM, Ward M, Younes M, Crombach S, Smith O, Hanly PJ. Sleep monitoring in 
the intensive care unit: comparison of nurse assessment, actigraphy and 
polysomnography. Intensive Care Med. 2008;34(11):2076-2083. 
Beltrami FG, Nguyen XL, Pichereau C, Maury E, Fleury B, Fagondes S. Sleep in the 
intensive care unit. J Bras Pneumol. 2015;41(6):539-546. 
Bihari S, Doug McEvoy R, Matheson E, Kim S, Woodman RJ, Bersten AD. Factors 
affecting sleep quality of patients in intensive care unit. J Clin Sleep Med. 2012;8(3):301-
307. 
Bourne RS, Mills GH, Minelli C. Melatonin therapy to improve nocturnal sleep in 
critically ill patients: encouraging results from a small randomised controlled trial. Crit 
Care. 2008;12(2):R52. 
Brouwer A, Asare Bediako I, Paszkiewicz RL, Kolka CM, Bergman RN, Broussard JL. 
Impact of sleep deprivation and high-fat feeding on insulin sensitivity and beta cell 
function in dogs. Diabetologia. 2020;63(4):875-884. 
Champagne T, Mullen B, Dickson D, Krishnamurty S. Evaluating the Safety and 
Effectiveness of the Weighted Blanket With Adults During an Inpatient Mental Health 
Hospitalization. Occupational Therapy in Mental Health. 2015;31(3):211-233. 
Chen HY, Yang H, Chi HJ, Chen HM. Parasympathetic effect of deep pressure input on 
third molar extraction in adolescents. J Formos Med Assoc. 2019;118(9):1317-1324. 
 65 
Cohen DA, Wang W, Wyatt JK, et al. Uncovering Residual Effects of Chronic Sleep 
Loss on Human Performance. Science Translational Medicine. 2010;2(14):14ra13. 
Dennis CM, Lee R, Woodard EK, Szalaj JJ, Walker CA. Benefits of quiet time for neuro-
intensive care patients. Journal of Neuroscience Nursing.42(4):217-224. 
Devlin JW, Skrobik Y, Gélinas C, et al. Clinical Practice Guidelines for the Prevention 
and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep 
Disruption in Adult Patients in the ICU. Crit Care Med. 2018;46(9):e825-e873. 
Dew MA, Hoch CC, Buysse DJ, et al. Healthy older adults' sleep predicts all-cause 
mortality at 4 to 19 years of follow-up. Psychosomatic Medicine.65(1):63-73. 
Dlin BM, Rosen H, Dickstein K, Lyons JW, Fischer HK. The problems of sleep and rest 
in the intensive care unit. Psychosomatics. 1971;12(3):155-163. 
Ekholm B, Spulber S, Adler M. A randomized controlled study of weighted chain 
blankets for insomnia in psychiatric disorders. J Clin Sleep Med. 2020. 
Elliott R, McKinley S, Cistulli P, Fien M. Characterisation of sleep in intensive care 
using 24-hour polysomnography: an observational study. Crit Care. 2013;17(2):R46. 
Engwall M, Fridh I, Johansson L, Bergbom I, Lindahl B. Lighting, sleep and circadian 
rhythm: An intervention study in the intensive care unit. Intensive Crit Care Nurs. 
2015;31(6):325-335. 
Eron K, Kohnert L, Watters A, Logan C, Weisner-Rose M, Mehler PS. Weighted Blanket 
Use: A Systematic Review. Am J Occup Ther. 2020;74(2):7402205010p7402205011-
7402205010p7402205014. 
Fakhr-Movahedi A, Mirmohammadkhani M, Ramezani H. Effect of milk-honey mixture 
on the sleep quality of coronary patients: A clinical trial study. Clin Nutr ESPEN. 
2018;28:132-135. 
Franck L, Tourtier JP, Libert N, Grasser L, Auroy Y. How did you sleep in the ICU? Crit 
Care. 2011;15(2):408. 
Freedman NS, Gazendam J, Levan L, Pack AI, Schwab RJ. Abnormal sleep/wake cycles 
and the effect of environmental noise on sleep disruption in the intensive care unit. Am J 
Respir Crit Care Med. 2001;163(2):451-457. 
Gee BM, Peterson TG, Buck A, Lloyd K. Improving sleep quality using weighted 
blankets among young children with an autism spectrum disorder. International Journal 
of Therapy and Rehabilitation. 2016;23(4):173-181. 
Gringras P, Green D, Wright B, et al. Weighted blankets and sleep in autistic children--a 
randomized controlled trial. Pediatrics. 2014;134(2):298-306. 
 66 
Guo X, Zheng L, Wang J, et al. Epidemiological evidence for the link between sleep 
duration and high blood pressure: A systematic review and meta-analysis. Sleep 
Medicine. 2013;14(4):324-332. 
Helton MC, Gordon SH, Nunnery SL. The correlation between sleep deprivation and the 
intensive care unit syndrome. Heart Lung. 1980;9(3):464-468. 
Hu RF, Jiang XY, Chen J, et al. Non-pharmacological interventions for sleep promotion 
in the intensive care unit. Cochrane Database Syst Rev. 2015;2015(10):Cd008808. 
Hu RF, Jiang XY, Hegadoren KM, Zhang YH. Effects of earplugs and eye masks 
combined with relaxing music on sleep, melatonin and cortisol levels in ICU patients: a 
randomized controlled trial. Crit Care. 2015;19(1):115. 
Irwin MR. Why sleep is important for health: a psychoneuroimmunology perspective. 
Annu Rev Psychol. 2015;66:143-172. 
Jansson M, Linton SJ. The development of insomnia within the first year: a focus on 
worry. Br J Health Psychol. 2006;11(Pt 3):501-511. 
Jha PK, Foppen E, Kalsbeek A, Challet E. Sleep restriction acutely impairs glucose 
tolerance in rats. Physiol Rep. 2016;4(12). 
Jitomir J, Willoughby DS. Cassia cinnamon for the attenuation of glucose intolerance and 
insulin resistance resulting from sleep loss. J Med Food. 2009;12(3):467-472. 
Kamdar BB, King LM, Collop NA, et al. The effect of a quality improvement 
intervention on perceived sleep quality and cognition in a medical ICU. Crit Care Med. 
2013;41(3):800-809. 
Kamdar BB, Knauert MP, Jones SF, Parsons EC, Parthasarathy S, Pisani MA. 
Perceptions and Practices Regarding Sleep in the Intensive Care Unit. A Survey of 1,223 
Critical Care Providers. Ann Am Thorac Soc. 2016;13(8):1370-1377. 
Kamdar BB, Needham DM, Collop NA. Sleep deprivation in critical illness: its role in 
physical and psychological recovery. J Intensive Care Med. 2012;27(2):97-111. 
Kamdar BB, Niessen T, Colantuoni E, et al. Delirium transitions in the medical ICU: 
exploring the role of sleep quality and other factors. Crit Care Med. 2015;43(1):135-141. 
Kelly FE, Fong K, Hirsch N, Nolan JP. Intensive care medicine is 60 years old: the 
history and future of the intensive care unit. Clin Med (Lond). 2014;14(4):376-379. 
Knauert MP, Gilmore EJ, Murphy TE, et al. Association between death and loss of stage 
N2 sleep features among critically Ill patients with delirium. J Crit Care. 2018;48:124-
129. 
Knauert MP, Haspel JA, Pisani MA. Sleep Loss and Circadian Rhythm Disruption in the 
Intensive Care Unit. Clin Chest Med. 2015;36(3):419-429. 
 67 
Knauert MP, Malik V, Kamdar BB. Sleep and sleep disordered breathing in hospitalized 
patients. Semin Respir Crit Care Med. 2014;35(5):582-592. 
Knauert MP, Pisani M, Redeker N, et al. Pilot study: an intensive care unit sleep 
promotion protocol. BMJ Open Respir Res. 2019;6(1):e000411. 
Knauert MP, Redeker NS, Yaggi HK, Bennick M, Pisani MA. Creating Naptime: An 
Overnight, Nonpharmacologic Intensive Care Unit Sleep Promotion Protocol. J Patient 
Exp. 2018;5(3):180-187. 
Knauert MP, Yaggi HK, Redeker NS, Murphy TE, Araujo KL, Pisani MA. Feasibility 
study of unattended polysomnography in medical intensive care unit patients. Heart 
Lung. 2014;43(5):445-452. 
Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR. Mortality associated 
with sleep duration and insomnia. 
Locihová H, Axmann K, Padyšáková H, Fejfar J. Effect of the use of earplugs and eye 
mask on the quality of sleep in intensive care patients: a systematic review. J Sleep Res. 
2018;27(3):e12607. 
Mallon L, Broman JE, Hetta J. Sleep complaints predict coronary artery disease mortality 
in males: a 12-year follow-up study of a middle-aged Swedish population. Journal of 
Internal Medicine.251(3):207-216. 
Marra A, McGrane TJ, Henson CP, Pandharipande PP. Melatonin in Critical Care. Crit 
Care Clin. 2019;35(2):329-340. 
McKinley S, Fien M, Elliott R, Elliott D. Sleep and psychological health during early 
recovery from critical illness: an observational study. J Psychosom Res. 2013;75(6):539-
545. 
Mistraletti G, Taverna M, Sabbatini G, et al. Actigraphic monitoring in critically ill 
patients: preliminary results toward an "observation-guided sedation". Journal of Critical 
Care.24(4):563-567. 
Mo Y, Scheer CE, Abdallah GT. Emerging Role of Melatonin and Melatonin Receptor 
Agonists in Sleep and Delirium in Intensive Care Unit Patients. J Intensive Care Med. 
2016;31(7):451-455. 
Morgenthaler T, Alessi C, Friedman L, et al. Practice parameters for the use of actigraphy 
in the assessment of sleep and sleep disorders: an update for 2007. Sleep. 
2007;30(4):519-529. 
Mullen B, Champagne T, Krishnamurty S, Dickson D, Gao RX. Exploring the Safety and 
Therapeutic Effects of Deep Pressure Stimulation Using a Weighted Blanket. 
Occupational Therapy in Mental Health. 2008;24(1):65-89. 
 68 
Naik RD, Gupta K, Soneja M, Elavarasi A, Sreenivas V, Sinha S. Sleep Quality and 
Quantity in Intensive Care Unit Patients: A Cross-sectional Study. Indian J Crit Care 
Med. 2018;22(6):408-414. 
Nicolás A, Aizpitarte E, Iruarrizaga A, Vázquez M, Margall A, Asiain C. Perception of 
night-time sleep by surgical patients in an intensive care unit. Nurs Crit Care. 
2008;13(1):25-33. 
Novak T, Scanlan J, McCaul D, MacDonald N, Clarke T. Pilot study of a sensory room 
in an acute inpatient psychiatric unit. Australas Psychiatry. 2012;20(5):401-406. 
Oto J, Yamamoto K, Koike S, Imanaka H, Nishimura M. Effect of daily sedative 
interruption on sleep stages of mechanically ventilated patients receiving midazolam by 
infusion. Anaesth Intensive Care. 2011;39(3):392-400. 
Ozer O, Ozbala B, Sari I, et al. Acute sleep deprivation is associated with increased QT 
dispersion in healthy young adults. Pacing Clin Electrophysiol. 2008;31(8):979-984. 
Özlü ZK, Bilican P. Effects of Aromatherapy Massage on the Sleep Quality and 
Physiological Parameters of Patients in a Surgical Intensive Care Unit Afr J Tradit 
Complement Altern Med. 2017;14(3):83-88. 
Pagnucci N, Tolotti A, Cadorin L, Valcarenghi D, Forfori F. Promoting nighttime sleep 
in the intensive care unit: Alternative strategies in nursing. Intensive Crit Care Nurs. 
2019;51:73-81. 
Pisani MA, Kong SYJ, Kasl SV, Murphy TE, Araujo KLB, Van Ness PH. Days of 
delirium are associated with 1-year mortality in an older intensive care unit population. 
Am J Respir Crit Care Med. 2009;180(11):1092-1097. 
Poongkunran C, John SG, Kannan AS, Shetty S, Bime C, Parthasarathy S. A meta-
analysis of sleep-promoting interventions during critical illness. Am J Med. 
2015;128(10):1126-1137.e1121. 
Pulak LM, Jensen L. Sleep in the Intensive Care Unit: A Review. J Intensive Care Med. 
2016;31(1):14-23. 
Raj R, Ussavarungsi K, Nugent K. Accelerometer-based devices can be used to monitor 
sedation/agitation in the intensive care unit. Journal of Critical Care.29(5):748-752. 
Richards K. Techniques for measurement of sleep in critical care. Focus Crit Care. 
1987;14(4):34-40. 
Sadeh A. The role and validity of actigraphy in sleep medicine: an update. Sleep 
Medicine Reviews. 2011;15(4):259-267. 
Schwab KE, Ronish B, Needham DM, To AQ, Martin JL, Kamdar BB. Actigraphy to 
Evaluate Sleep in the Intensive Care Unit. A Systematic Review. Ann Am Thorac Soc. 
2018;15(9):1075-1082. 
 69 
Summe V, Baker RB, Eichel MM. Safety, Feasibility, and Effectiveness of Weighted 
Blankets in the Care of Infants With Neonatal Abstinence Syndrome: A Crossover 
Randomized Controlled Trial. Adv Neonatal Care. 2020. 
Vinson J, Powers J, Mosesso K. Weighted Blankets: Anxiety Reduction in Adult Patients 
Receiving Chemotherapy. Clin J Oncol Nurs. 2020;24(4):360-368. 
Walder B, Francioli D, Meyer JJ, Lancon M, Romand JA. Effects of guidelines 
implementation in a surgical intensive care unit to control nighttime light and noise 
levels. Critical Care Medicine.28(7):2242-2247. 
Wallace CJ, Robins J, Alvord LS, Walker JM. The effect of earplugs on sleep measures 
during exposure to simulated intensive care unit noise. Am J Crit Care. 1999;8(4):210-
219. 
Watson NF, Badr MS, Belenky G, et al. Recommended Amount of Sleep for a Healthy 
Adult: A Joint Consensus Statement of the American Academy of Sleep Medicine and 
Sleep Research Society. J Clin Sleep Med. 2015;11(6):591-592. 
Weinhouse GL. Pharmacology I: effects on sleep of commonly used ICU medications. 
Crit Care Clin. 2008;24(3):477-491, vi. 
Weinhouse GL, Schwab RJ, Watson PL, et al. Bench-to-bedside review: delirium in ICU 
patients - importance of sleep deprivation. Crit Care. 2009;13(6):234. 
White DP, Douglas NJ, Pickett CK, Zwillich CW, Weil JV. Sleep deprivation and the 
control of ventilation. Am Rev Respir Dis. 1983;128(6):984-986. 
 
